DEVELOPMENT AND EVALUATION OF ORAL CONTROLLED RELEASE MATRIX TABLETS OF LAMIVUDINE: OPTIMIZATION AND IN VITRO-IN VIVO STUDIES
Keywords:
Hydrophilic and hydrophobic polymer, Central composite design, Quadratic model, In vitro-in vivo correlation, Response surface methodologyAbstract
Objectives: To develop and evaluate a controlled release matrix tablets containing lamivudine (LAM).
Methods: A central composite design (CCD) of the experiment were employed with the amount of hydrophilic polymer (HPMC K100M) (X1) and amount of hydrophobic polymer cellulose acetate phthalate (X2) as independent variables. Four response variables were considered in the formulation, which includes the % drug release at 1hr (Y1), % drug release at 8hr (Y2), diffusion coefficient (Y3) and T50% (Y4). The design was quantitatively evaluated by the quadratic model.
Results: Statistical analysis revealed that factor X1 was found to be highly significant for responses Y2 and Y4, whereas factor X2 for response Y1. The quadratic factor of X1 and X2 is found to be highly significant in response Y3. A numerical optimization technique for desirability function was used to optimize the response variables with different target and the observed responses were highly agreed with experimental values. The response Y1-Y4 and the optimized formulation was arrived by restricting to 17% < Y1 > 18%; 72.0% < Y2 > 75%; 0.55 < Y3 > 0.65; 4.2 < Y4 > 4.52h. The results showed a good relationship between the experimented and predicted values. The dissolution profiles of the optimal formulation before and after stability studies were evaluated by using a similarity factor (Æ’2) and were found to be similar. In vivo studies indicate that the formula generated by CCD showed a controlled release profile.
Conclusion: The results of in vivo studies revealed that the optimized formulation exhibited a controlled release of lamivudine.
Â
Downloads
References
Physicians’ Desk Reference. 54th ed. Montvale, NJ: Medical Economics Company; 2000.
Charles F. Antiretroviral Agents and Treatment of HIV Infection. In: Laurence B, Bruce C, Bjorn K, editors. Goodman and Gilman’s, The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill; 2011. p. 1629-40.
Piliero PJ. Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2004;37:S2–S12.
Betty JD, Jennifer C. Human Immunodeficiency Virus Infection-Antiretroviral Therapy. In: Richard AH, David JQ, editors. The Textbook of Therapeutics: Drug and Disease Management. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 2137-58.
Moyle G. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin Ther 2000;22:911-36.
Atul K, Ashok KT, Narendra KJ, Subheet J. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm Sci Tech 2006;7 Suppl 1:E1-E9.
Al-saidan SM, Krishnaiah YSR, Patro S, Satyaranayana V. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. AAPS Pharm Sci Tech 2005;6 Suppl 1:E14-E21.
Ravi PR, Ganga S, Saha RN. Design and study of lamivudine oral controlled release tablets. AAPS Pharm Sci Tech 2007;8 Suppl 4:167-75.
Badshah A, Subhan F, Shah NH, Bukhari NI, Saeed M Shah KU. Once daily controlled release matrix tablet of prochlorperazine maleate: Influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability. Drug Dev Ind Pharm 2012;38 Suppl 2:190-9.
Singh B, Rani A, Babita, Ahuja N, Kapil R. Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride. Sci Pharm 2010;78 Suppl 2:303-23.
Emeje MO, Kunle OO, Ofoefule SI. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix. Acta Pharm 2006;56 Suppl 3:325-35.
Palmer D, Levina M, Nokhodchi A, Douroumis D, Farrell T, Rajabi-Siahboomi A. The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices. AAPS Pharm Sci Tech 2011;12 Suppl 3:862-71.
Teixeira, Antonio ZA. Hydroxypropylcellulose controlled release tablet matrix prepared by wet granulation: effect of powder properties and polymer composition. Braz Arch Biol Technol 2009;52 Suppl 1:157-62.
Matharu AS, Motto MG, Patel MR, Simonelli AP, Dave RH. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS). J Pharm Sci 2011;100 Suppl 1:150-63.
Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J Control Release 2001;70 Suppl 3:383-91.
Cao QR, Choi YW, Cui JH, Lee BJ. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. J Controlled Release 2005;108(2 Suppl 3):351-61.
Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm 2008;362(1 Suppl 2):118-25.
Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm 2001;52 Suppl 2:181-90.
Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 2005;289(1, Suppl 2):87–95.
Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm Sci Tech 2006;7 Suppl 1:E19-E28.
Kuksal A, Tiwary AK, Jain NK, Jain S. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm Sci Tech 2006;7 Suppl 1:E1-E9.
Emori H, Sakuraba Y, Takahashi K, Nishihata T, Mayumi T. Prospective validation of high-shear wet granulation process by wet granule sieving method. II. Utility of wet granule sieving method. Drug Dev Ind Pharm 1997;23 Suppl 2:203-15.
United States Pharmacopoeia 34-National Formulary 29. The United States Pharmacopeial Convention, Rockville, MD; 2011.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci 1983;72 Suppl 10:1189-91.
Lee PI. Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels. J Pharm Sci 1984;73 Suppl 10:1344-47.
Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13 Suppl 2:123-33.
Kano EK, dos Reis Serra CH, Koono EE, Andrade SS, Porta V. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies. Int J Pharm 2005;297(1 Suppl 2):73-79.
Chandran S, Asghar LF, Mantha N. Design and evaluation of ethyl cellulose based matrix tablets of ibuprofen with pH modulated release kinetics. Indian J Pharm Sci 2008;70 Suppl 5:596-02.
Kar SK, Panigrahy RN, Mahale AM. Design and development of indomethacin matrix tablet with pH modulated release kinetics. Int J Compreh Pharm 2011;2 Suppl 1:1-5.
Narendra C, Srinath MS. Formulation development of oral timed-release press-coated tablets: Optimization and in vivo studies. Lat Am J Pharm 2011:30 Suppl 6:1142-51.
Meka VS, Nali SR, Songa AS, Battu JR, Kolapalli VRM. Statistical optimization of a novel excipient (CMEC) based gastro retentive floating tablets of propranolol HCl and it’s in vivo buoyancy characterization in healthy human volunteers. DARU J Pharm Sci 2012;20:21.